Contact Information
Name: Basim Awad
Company: SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE
Position: Accountant
Professional Background
Current Role:
Accountant at SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE
Tenure: Since January 2010 (14 years and 9 months, as of September 2024)
Location: Egypt
Responsibilities:
- Managing financial records and accounting tasks
- Overseeing financial transactions and ensuring accuracy and compliance with regulations
- Contributing to financial strategy and analysis within the company
Relevant Experience:
Prior to his current position, there are indications he might have served as an Account Assistant at Multi Electric Co., although this information needs corroboration due to limited verification.
Company Information
SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE
Location: Mubarak 1st Industrial Zone, Monufia, Egypt
Industry: Pharmaceuticals
Description: SIGMA PHARMACEUTICAL INDUSTRIES (S.P.I) SAE is a leading company in the pharmaceutical manufacturing sector, positioned prominently in the Egyptian market. The company is involved in producing a wide range of medicinal products that cater to various therapeutic needs.
Key Information:
- Business Focus: Developing and manufacturing pharmaceutical products
- Market Position: Strong presence in Egypt, contributing significantly to the healthcare sector through innovative solutions and high-quality products.
Actionable Insights
1. Tenure and Expertise: With over 14 years at SIGMA PHARMACEUTICAL INDUSTRIES, Basim Awad possesses deep institutional knowledge and expertise in the company's financial operations.
2. Strategic Role: His long-standing role suggests he is likely a trusted and influential figure within the organization, potentially involved in strategic financial decision-making.
3. Industry Insight: Engaging Basim could provide valuable insights into the pharmaceutical industry's financial management practices and challenges.
Recommendation: Establish rapport by acknowledging his extensive experience and understanding the critical role he plays in SIGMA PHARMACEUTICAL INDUSTRIES. Moreover, discussing industry-specific financial strategies and innovations might resonate well, given his background.
This professional, data-oriented report encapsulates the key details and insights derived from the provided information, organized logically and formatted with markdown for emphasis.
